Page last updated: 2024-08-24

fanasil, pyrimethamine drug combination and Asymptomatic Conditions

fanasil, pyrimethamine drug combination has been researched along with Asymptomatic Conditions in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G1
Falade, CO; Fayemiwo, SA; Meyer, CG; Nguetse, CN; Ojurongbe, O; Ojurongbe, TA; Thomas, BN; Velavan, TP1
Boudova, S; Cohee, LM; Joshi, S; Kalilani-Phiri, L; Kamiza, S; Laufer, MK; Makwakwa, K; Mawindo, P; Muehlenbachs, A; Mukadam, R; Seydel, KB; Taylor, TE; Thesing, P1
Abdulla, SM; Charlwood, JD; Ferguson, HM; Huho, BJ; Kachur, SP; Kihonda, A; Kihonda, J; Killeen, GF; Lengeler, C; Smith, TA; Tami, A1

Trials

1 trial(s) available for fanasil, pyrimethamine drug combination and Asymptomatic Conditions

ArticleYear
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10

    Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine

2019

Other Studies

3 other study(ies) available for fanasil, pyrimethamine drug combination and Asymptomatic Conditions

ArticleYear
High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
    Pathogens and global health, 2018, Volume: 112, Issue:2

    Topics: Adolescent; Adult; Animals; Antimalarials; Asymptomatic Diseases; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Microscopy; Mutation, Missense; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult

2018
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
    Malaria journal, 2014, Jul-15, Volume: 13

    Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Asymptomatic Diseases; DNA, Protozoan; Drug Administration Schedule; Drug Combinations; Drug Resistance; Erythrocytes; Ethanolamines; False Negative Reactions; Female; Fetal Diseases; Fluorenes; Follow-Up Studies; Hemeproteins; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria; Malawi; Parasitemia; Placenta; Plasmodium; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimesters; Prevalence; Pyrimethamine; Quinine; Sulfadoxine

2014
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
    Malaria journal, 2012, Apr-18, Volume: 11

    Topics: Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Asymptomatic Diseases; Child, Preschool; Culicidae; Disease Vectors; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania

2012